La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Carbidopa (therapeutic use) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Carbidopa (pharmacology) < Carbidopa (therapeutic use) < Carbon  Facettes :

List of bibliographic references indexed by Carbidopa (therapeutic use)

Number of relevant bibliographic references: 17.
Ident.Authors (with country if any)Title
000524 (2015) Paolo Solla [Italie] ; Alfonso Fasano [Canada] ; Antonino Cannas [Italie] ; Francesco Marrosu [Italie]Suicide and dopamine agonist withdrawal syndrome in Parkinson's disease.
000568 (2015) Constant V. M. Verschuur [Pays-Bas] ; S. R. Suwijn [Pays-Bas] ; B. Post [Pays-Bas] ; M. Dijkgraaf [Pays-Bas] ; B. R. Bloem [Pays-Bas] ; J. J. Van Hilten [Pays-Bas] ; T. Van Laar [Pays-Bas] ; G. Tissingh [Pays-Bas] ; G. Deuschl [Allemagne] ; A. E. Lang [Canada] ; R. J. De Haan [Pays-Bas] ; R. M. A. De Bie [Pays-Bas]Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson’s disease: the LEAP-study
000788 (2015) Alison C. Simioni ; Alain Dagher ; Lesley K. FellowsCompensatory striatal–cerebellar connectivity in mild–moderate Parkinson's disease
001906 (2011) N. Auclair-Ouellet [Canada] ; S. Chantal [Canada] ; L. Cantin [Canada] ; M. Prud'Homme [Canada] ; M. Langlois [Canada] ; J. Macoir [Canada]Transient Executive Dysfunction Following STN- DBS in Parkinson's Disease
002415 (2008) Jon B. Doan [Canada] ; Kyle G. Melvin [Canada] ; Ian Q. Whishaw [Canada] ; Oksana Suchowersky [Canada]Bilateral impairments of skilled reach-to-eat in early Parkinson's disease patients presenting with unilateral or asymmetrical symptoms
002916 (2006) Jon Doan [Canada] ; Ian Q. Whishaw [Canada] ; Sergio M. Pellis [Canada] ; Oksana Suchowersky [Canada] ; Lesley A. Brown [Canada]Motor deficits in parkinsonian reaching : Dopa-sensitivity influenced by real-world task constraint
002985 (2005) Stanley Fahn [États-Unis]Does levodopa slow or hasten the rate of progression of Parkinson's disease?
002C06 (2004) Connie Marras [Canada] ; Anthony Lang [Canada] ; Murray Krahn [Canada] ; George Tomlinson [Canada] ; Gary Naglie [Canada]Quality of life in early Parkinson's disease: Impact of dyskinesias and motor fluctuations
002F27 (2003) Lisa M. Inkster [Canada] ; Janice J. Eng [Canada] ; Donna L. Macintyre [Canada] ; A. Jon Stoessl [Canada]Leg muscle strength is reduced in Parkinson's disease and relates to the ability to rise from a chair
003A68 (1997) H. Shinotoh [Canada] ; F J Vingerhoets ; C S Lee ; R J Uitti ; M. Schulzer ; D B Calne ; J. TsuiLamotrigine trial in idiopathic parkinsonism: a double-blind, placebo-controlled, crossover study.
003C69 (1997) R. Kumar [Canada] ; A. E. Lang [Canada]Coexistence of tics and parkinsonism : Evidence for non-dopaminergic mechanisms in tic pathogenesis
004041 (1995) Angela Lang [Canada]Hemiatrophy, juvenile‐onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult‐onset hemiparkinsonism: The spectrum of hemiparkinsonism‐hemiatrophy syndrome
004107 (1995) C. Nahmias [Canada] ; L. Wahl ; R. Chirakal ; G. Firnau ; E. S. GarnettA probe for intracerebral aromatic amino-acid decarboxylase activity : distribution and kinetics of [18F]6-fluoro-L-m-tyrosine in the human brain
004846 (1990) R F Peppard [Canada] ; C S Lu ; N S Chu ; P. Teal ; W R Martin ; D B CalneParkinsonism with neuroacanthocytosis.
004B26 (1989) J. K. Tsui ; S. Ross ; K. Poulin ; J. Douglas ; D. Postnikoff ; S. Calne ; W. Woodward ; D. B. CalneThe effect of dietary protein on the efficacy of L-dopa: a double-blind study
004E01 (1987) I. Libman ; M. J. Gawel ; R. J. Riopelle ; S. BouchardA comparison of bromocriptine (Parlodel®) and levodopa-carbidopa (Sinemet®) for treatment of "De Novö Parkinson's disease patients
005616 (????) E. Shahar [Canada] ; R. Lambert ; P A Hwang ; H J HoffmanObstructive hydrocephalus-induced parkinsonism. I: Decreased basal ganglia regional blood flow.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Carbidopa (therapeutic use)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Carbidopa (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Carbidopa (therapeutic use)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022